TyraTech, Inc. Result of Special Meeting & Director Shareholdings (5471N)

TIDMTYR TIDMTYRU

RNS Number : 5471N

TyraTech, Inc.

28 July 2014

For immediate release

TyraTech, Inc

("TyraTech" or "the Company")

RESULT OF SPECIAL MEETING AND DIRECTORS' SHAREHOLDINGS

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM JAPAN, CANADA OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A BREACH OF THE RELEVANT SECURITIES LAWS OF SUCH JURISDICTION.

Further to the announcement dated 16 July 2014, TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focusing on nature-derived insect and parasite control products, is pleased to announce that at the Special Meeting held earlier today, each of the resolutions as set out in the notice of Special Meeting was duly passed. Accordingly, the Fundraise (as defined in the circular dated 16 July 2014) is now unconditional save for Admission.

Accordingly, the Company has approved, subject only to Admission, the issue of 50,000,000 new common shares in the capital of the Company of $0.001 each (the "New Common Shares") at 7 pence per share to the investors participating in the Fundraise.

Application has been made to the London Stock Exchange for the New Common Shares to be admitted to trading on AIM ("Admission"). It is now expected that Admission and the commencement of dealings will take place at 8 a.m. on 31 July 2014.

Following Admission, the Company will have 256,168,068 common shares of $0.001 each ("Common Shares") in issue, of which 1,084,413 will continue to be held in Treasury. Therefore, the total number of voting rights in the Company will be 255,083,655 ("Total Voting Rights"). The number of restricted Common Shares trading under TIDM 'TYR' following Admission will be 161,266,592 and the number of unrestricted Common Shares trading under TIDM 'TYRU' following Admission will be 94,901,476.

Furthermore, following Admission, there are changes to the following directors' holdings of Common Shares:

Alan Reade, who subscribed for 214,298 New Common Shares pursuant to the Subscription, is now interested in 12,700,656 Common Shares in the Company; representing an interest of 4.98% of the total voting rights of the Company.

Bruno Jactel, who subscribed for 142,857 New Common Shares pursuant to the Subscription, is now interested in 2,002,424 Common Shares in the Company; representing an interest of 0.79% of the total voting rights of the Company.

Barry Riley, who subscribed for 142,857 New Common Shares pursuant to the Subscription, is now interested in 3,198,413 Common Shares in the Company; representing an interest of 1.25% of the total voting rights of the Company.

James Hills, who subscribed for 142,857 New Common Shares pursuant to the Subscription, is now interested in 1,190,757 Common Shares in the Company representing an interest of 0.47% of the total voting rights of the Company.

END

For further information please contact:

 
TyraTech Inc. 
 Alan Reade, Non-executive Chairman                  Tel: [phone] 
 Bruno Jactel, Chief Executive Officer               Tel: [phone] 
SPARK Advisory Partners Limited, Nominated Adviser  Tel: [phone] 
 Mark Brady/Matt Davis 
Allenby Capital, Joint Broker                       Tel: [phone] 
 Chris Crawford 
Whitman Howard Ltd, Joint Broker                     Tel: [phone] 
 Ranald McGregor Smith/Niall Devins 
Walbrook, Financial PR and IR                       Tel: [phone] 
 Bob Huxford / Guy McDougall 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLLFVRDSITFIS